Supply of treatments for the BOLERO study by CHRU.
This notice concerns the supply of treatments required for the BOLERO study, issued by the Centre Hospitalier Régional Universitaire (CHRU) in France. The procurement involves specific medical treatments for a clinical study, likely requiring pharmaceutical products. The buyer is a university hospital center serving patients in the region. No specific qualifications or set-asides are mentioned, but the study context implies specialized medical supplies. The scale is not explicitly stated, but it is likely a limited procurement for research purposes.